Avidity Partners Management LP Sells 5,000 Shares of Cigna Group $CI

Avidity Partners Management LP trimmed its position in Cigna Group (NYSE:CI) by 30.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 11,600 shares of the health services provider’s stock after selling 5,000 shares during the quarter. Cigna Group makes up 0.9% of Avidity Partners Management LP’s portfolio, making the stock its 23rd biggest position. Avidity Partners Management LP’s holdings in Cigna Group were worth $3,193,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after buying an additional 414,834 shares in the last quarter. State Street Corp increased its holdings in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after buying an additional 224,122 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after acquiring an additional 903,334 shares during the last quarter. Dodge & Cox lifted its stake in shares of Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Finally, Sanders Capital LLC lifted its stake in shares of Cigna Group by 0.5% in the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after acquiring an additional 35,150 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $297.77 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The stock has a market cap of $78.77 billion, a price-to-earnings ratio of 12.62, a P/E/G ratio of 1.15 and a beta of 0.28. The company’s fifty day moving average is $282.53 and its 200 day moving average is $278.01.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the previous year, the firm posted $6.74 earnings per share. Cigna Group’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s payout ratio is currently 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on CI shares. Barclays cut Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $310.00 to $304.00 in a research note on Tuesday, May 26th. Robert W. Baird set a $337.00 price target on Cigna Group in a research note on Friday, May 1st. Jefferies Financial Group dropped their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, June 6th. Finally, Guggenheim increased their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $338.80.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.